icon-folder.gif   Conference Reports for NATAP  
 
  EASL - European Association
for the Study of the Liver
May 7-10, 2025
Amsterdam the Netherlands
 Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Glecaprevir/Pibrentasvir in
Acute HCV Participants With a History of Prior Infection(s)
 
 
  EASL 2025 May 7-10 Amsterdam

0507251

0507252

0507253

0507254

0507255

0507256

0507257

0507258

0507259

05072510

05072511